Médecins Sans Frontières (MSF) is poised to introduce long-acting cabotegravir (CAB-LA) for pre-exposure prophylaxis (PrEP) in its southern African projects. This injectable, administered every two months, offers a significant advancement in HIV prevention, potentially curbing the epidemic, particularly among high-risk populations.
Zimbabwe is taking a significant stride towards eliminating mother-to-child transmission (MTCT) of HIV, syphilis, and Hepatitis B by introducing the universal Hepatitis B birth dose vaccination.
The Union Zimbabwe Trust (UZT) has successfully concluded the TB REACH project, a two-year initiative aimed at improving access to treatment for Drug-Resistant Tuberculosis (DR-TB) patients in Zimbabwe.
Researchers at these three African universities are playing key roles in helping to limit the number of newborns dying globally each year from sepsis.
Faced with the problem of insufficient hospital beds, Naom Monari realised that as a nurse she could better help people at their homes
